title: Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study.
authors.forename: J K
authors.initials: JK
authors.lastname: Lamba
authors.forename: S
authors.initials: S
authors.lastname: Pounds
authors.forename: X
authors.initials: X
authors.lastname: Cao
authors.forename: J R
authors.initials: JR
authors.lastname: Downing
authors.forename: D
authors.initials: D
authors.lastname: Campana
authors.forename: R C
authors.initials: RC
authors.lastname: Ribeiro
authors.forename: C-H
authors.initials: CH
authors.lastname: Pui
authors.forename: J E
authors.initials: JE
authors.lastname: Rubnitz
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD / Q000235:genetics*; D015214:Antigens, Differentiation, Myelomonocytic / Q000235:genetics*; D000079982:Gemtuzumab; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics*; D018365:Neoplasm, Residual / Q000235:genetics; D010597:Pharmacogenetics; D010865:Pilot Projects; D011110:Polymorphism, Genetic; D063268:Sialic Acid Binding Ig-like Lectin 3
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; D063268:Sialic Acid Binding Ig-like Lectin 3; D000079982:Gemtuzumab